Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Cisplatin in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07697040 Clinical Landscape Report 2026
9 min read
Cisplatin in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07697040 Clinical Landscape Report 2026
15 October 2026
NCT07697040 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
Read →
[177Lu] Lu-RTX-2358 in metastatic non-small cell lung cancer: NCT07689643 Clinical Landscape Report 2026
9 min read
[177Lu] Lu-RTX-2358 in metastatic non-small cell lung cancer: NCT07689643 Clinical Landscape Report 2026
15 October 2026
NCT07689643 clinical landscape for metastatic non-small cell lung cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
SYS-6010 in Non-Small Cell Lung Cancer: NCT07692048 Clinical Landscape Report 2026
9 min read
SYS-6010 in Non-Small Cell Lung Cancer: NCT07692048 Clinical Landscape Report 2026
15 October 2026
NCT07692048 clinical landscape for Non-Small Cell Lung Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Citric Acid/Magnesium Oxide/Sodium Picosulfate in Colorectal Cancer: NCT07696793 Clinical Landscape Report 2026
9 min read
Citric Acid/Magnesium Oxide/Sodium Picosulfate in Colorectal Cancer: NCT07696793 Clinical Landscape Report 2026
15 October 2026
NCT07696793 clinical landscape for Colorectal Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Levocarnitine in Digestive System Disorders: PACTR202607817508518 Clinical Landscape Report 2026
9 min read
Levocarnitine in Digestive System Disorders: PACTR202607817508518 Clinical Landscape Report 2026
15 October 2026
PACTR202607817508518 clinical landscape for Digestive System Disorders: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
Read →
Canagliflozin Hemihydrate in Diabetes Mellitus, Type 2: NCT07711171 Clinical Landscape Report 2026
9 min read
Canagliflozin Hemihydrate in Diabetes Mellitus, Type 2: NCT07711171 Clinical Landscape Report 2026
15 October 2026
NCT07711171 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Albumin-Bound Paclitaxel in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07699185 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Locally Advanced Esophageal Squamous Cell Carcinoma: NCT07699185 Clinical Landscape Report 2026
15 October 2026
NCT07699185 clinical landscape for Locally Advanced Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and dev…
Read →
Mazdutide in Diabetes Mellitus, Type 2: NCT07713992 Clinical Landscape Report 2026
9 min read
Mazdutide in Diabetes Mellitus, Type 2: NCT07713992 Clinical Landscape Report 2026
15 October 2026
NCT07713992 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
S-531011 in Metastatic Colorectal Carcinoma: NCT07720115 Clinical Landscape Report 2026
9 min read
S-531011 in Metastatic Colorectal Carcinoma: NCT07720115 Clinical Landscape Report 2026
15 October 2026
NCT07720115 clinical landscape for Metastatic Colorectal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Tirzepatide in Overweight: NCT07715929 Clinical Landscape Report 2026
9 min read
Tirzepatide in Overweight: NCT07715929 Clinical Landscape Report 2026
15 October 2026
NCT07715929 clinical landscape for Overweight: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
ZP-6590 in Obesity: NCT07721597 Clinical Landscape Report 2026
9 min read
ZP-6590 in Obesity: NCT07721597 Clinical Landscape Report 2026
15 October 2026
NCT07721597 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Semaglutide (Novo Nordisk) in Obesity: NCT07728383 Clinical Landscape Report 2026
9 min read
Semaglutide (Novo Nordisk) in Obesity: NCT07728383 Clinical Landscape Report 2026
15 October 2026
NCT07728383 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →